ANTIBODY PREVALENCE TO HEPATITIS-C AND PARENTERAL TRANSMITTED VIRUS DISEASES IN INTRAVENOUS-DRUG-USERS

被引：0
作者：
NEUWALD, C [1 ]
PONT, J [1 ]
TOMASITS, J [1 ]
BAUER, K [1 ]
机构：
[1] STADT WIEN,KAISER FRANZ JOSEF SPITALS,MED ABT 3,A-1100 VIENNA,AUSTRIA
来源：
ACTA MEDICA AUSTRIACA | 1992年 / 19卷 / 02期
关键词：
IV DRUG USERS; HEPATITIS-C; HEPATITIS-B; HIV; HTLV-I;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Serum samples of 151 intravenous drug users were tested for markers of hepatitis B, hepatitis C, HIV and HTLV-I infection to estimate the prevalence of blood born virus infection in this high risk group. Anti-HCV antibodies were found in 75% of sera. Seroprevalence for HIV was found 13%, for hepatitis B markers 68% and none for HTLV-I. Multiple infections have been very frequent.
引用
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [41] Trends in Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Prevalence, Risk Behaviors, and Preventive Measures among Seattle Injection Drug Users Aged 18–30 Years, 1994–2004
    Richard D. Burt
    Holly Hagan
    Richard S. Garfein
    Keith Sabin
    Cindy Weinbaum
    Hanne Thiede
    Journal of Urban Health, 2007, 84 : 436 - 454
  • [42] PREVALENCE OF ANTIBODIES TO HEPATITIS-C VIRUS IN HIV-SEROPOSITIVE PATIENTS
    RANGER, S
    AUSSEL, L
    WEINBRECK, P
    LOUSTAUD, V
    ROGUES, AM
    MOUNIER, M
    DELPEYROUX, C
    DENIS, F
    PATHOLOGIE BIOLOGIE, 1991, 39 (02): : 126 - 130
  • [43] Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities
    Nasir, Abdul
    Todd, Catherine S.
    Stanekzai, M. Raza
    Bautista, Christian T.
    Botros, Boulos A.
    Scott, Paul T.
    Strathdee, Steffanie A.
    Tjaden, Jeffrey
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2011, 22 (02) : 145 - 152
  • [44] PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS, HEPATITIS-B VIRUS AND HEPATITIS-C VIRUS AMONG DIALYSIS PATIENTS
    PETROSILLO, N
    PURO, V
    IPPOLITO, G
    NEPHRON, 1993, 64 (04): : 636 - 639
  • [45] High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012)
    Malekinejad, Mohsen
    Navadeh, Soodabeh
    Lotfizadeh, Ali
    Rahimi-Movaghar, Afarin
    Amin-Esmaeili, Masoumeh
    Noroozi, Alireza
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 40 : 116 - 130
  • [46] Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services
    Harris, R. J.
    Hope, V. D.
    Morongiu, A.
    Hickman, M.
    Ncube, F.
    de Angelis, D.
    EPIDEMIOLOGY AND INFECTION, 2012, 140 (06) : 1054 - 1063
  • [47] Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia
    Vicknasingam, Balasingam
    Narayanan, Suresh
    Navaratnam, Visweswaran
    DRUG AND ALCOHOL REVIEW, 2009, 28 (04) : 447 - 454
  • [48] Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004
    Burt, Richard D.
    Hagan, Holly
    Garfein, Richard S.
    Sabin, Keith
    Weinbaum, Cindy
    Thiede, Hanne
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2007, 84 (03): : 436 - 454
  • [49] Prevalence of Hepatitis C infection in Malawi and lack of association with sexually transmitted diseases
    Maida, MJ
    Daly, CC
    Hoffman, I
    Cohen, MS
    Kumwenda, M
    Vernazza, PL
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2000, 16 (12) : 1183 - 1184
  • [50] CORRELATION BETWEEN SERUM GLOBULIN LEVELS AND HEPATITIS-C VIRUS-ANTIBODY
    PONIACHIK, J
    VELASCO, M
    HURTADO, C
    BRAHM, J
    CHESTA, J
    SEPULVEDA, C
    REVISTA MEDICA DE CHILE, 1993, 121 (07) : 752 - 756
12345